• Company Type For Profit
  • Phone Number +498974419166

GeneWake GmbH focuses on contract research in the vast field of biomarker analysis for oncology. We specialize in biomarker prescreening for patient stratification to ensure the best possible care for cancer patients. By employing bioinformatical algorithms based on knowledge in pathway structure and microarray data from public sources, it is

possible to limit biomarker screening to analysis on a low-density scale. This is not only cost efficient, but also more easily interpreted compared to high-density

methods like whole genome microarrays. Samples can be anything from fresh frozen or paraffin embedded tissue to whole blood. A typical output of a study would be a short list of 10-20 potential biomarkers, that are highly likely to carry changes on the DNA or protein level.

Lists Featuring This Company

Europe Acquired Companies With Fewer Than 10 Employees
3,830 Number of Organizations â€¢ $5.2B Total Funding Amount â€¢ 2,283 Number of Investors
Europe, Middle East, and Africa (EMEA) Product Research Companies
2,169 Number of Organizations â€¢ $1.4B Total Funding Amount â€¢ 562 Number of Investors
Germany Biotechnology Companies
1,322 Number of Organizations â€¢ $20.7B Total Funding Amount â€¢ 1,349 Number of Investors
Acquired Oncology Companies
200 Number of Organizations â€¢ $8.5B Total Funding Amount â€¢ 449 Number of Investors
GeneWake GmbH was acquired by R-Biopharm on Oct 13, 2015.

Frequently Asked Questions

Where is GeneWake GmbH's headquarters? GeneWake GmbH is located in Neuried, Bayern, Germany.Who are GeneWake GmbH's competitors? Alternatives and possible competitors to GeneWake GmbH may include BIMINI BiotechFida Biosystems, and Iome Bio.